Trillium Asset Management LLC Buys 4,625 Shares of HCP, Inc. (NYSE:HCP)

Share on StockTwits

Trillium Asset Management LLC boosted its stake in shares of HCP, Inc. (NYSE:HCP) by 1.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 384,055 shares of the real estate investment trust’s stock after acquiring an additional 4,625 shares during the quarter. Trillium Asset Management LLC’s holdings in HCP were worth $13,684,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Rational Advisors LLC increased its stake in HCP by 208.2% during the third quarter. Rational Advisors LLC now owns 1,578 shares of the real estate investment trust’s stock worth $56,000 after acquiring an additional 1,066 shares during the last quarter. Harvest Investment Services LLC bought a new stake in HCP during the third quarter worth approximately $284,000. Shoker Investment Counsel Inc. increased its stake in HCP by 1.9% during the third quarter. Shoker Investment Counsel Inc. now owns 30,923 shares of the real estate investment trust’s stock worth $1,101,000 after acquiring an additional 577 shares during the last quarter. Northwestern Mutual Investment Management Company LLC grew its stake in shares of HCP by 3.2% during the third quarter. Northwestern Mutual Investment Management Company LLC now owns 18,702 shares of the real estate investment trust’s stock valued at $666,000 after buying an additional 572 shares during the last quarter. Finally, D.A. Davidson & CO. grew its stake in shares of HCP by 3.4% during the third quarter. D.A. Davidson & CO. now owns 196,535 shares of the real estate investment trust’s stock valued at $7,003,000 after buying an additional 6,416 shares during the last quarter. 95.80% of the stock is currently owned by institutional investors.

In related news, COO Thomas Klaritch sold 35,014 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $36.02, for a total value of $1,261,204.28. Following the transaction, the chief operating officer now owns 230,529 shares of the company’s stock, valued at $8,303,654.58. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.13% of the stock is owned by corporate insiders.

A number of research analysts have recently commented on the company. Stifel Nicolaus upped their target price on HCP from $34.00 to $37.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. They noted that the move was a valuation call. Scotiabank set a $38.00 target price on HCP and gave the company a “buy” rating in a research note on Monday, September 30th. Barclays upped their target price on HCP from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. TheStreet raised HCP from a “c+” rating to a “b-” rating in a research note on Friday, August 2nd. Finally, ValuEngine cut HCP from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $36.78.

Shares of HCP remained flat at $$33.69 during mid-day trading on Wednesday. The stock had a trading volume of 4,242,895 shares, compared to its average volume of 2,801,829. The stock has a market capitalization of $17.57 billion, a PE ratio of 18.51, a P/E/G ratio of 6.81 and a beta of 0.22. The firm’s 50 day moving average is $36.13 and its 200-day moving average is $33.50. HCP, Inc. has a 1 year low of $26.58 and a 1 year high of $37.93. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.81 and a current ratio of 0.81.

HCP (NYSE:HCP) last released its earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.52). HCP had a net margin of 43.66% and a return on equity of 12.78%. The business had revenue of $538.00 million for the quarter, compared to the consensus estimate of $503.65 million. During the same period in the prior year, the company posted $0.44 EPS. The company’s quarterly revenue was up 18.0% compared to the same quarter last year. As a group, equities research analysts forecast that HCP, Inc. will post 1.75 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 19th. Investors of record on Monday, November 4th will be paid a $0.37 dividend. The ex-dividend date is Friday, November 1st. This represents a $1.48 annualized dividend and a yield of 4.39%. HCP’s dividend payout ratio (DPR) is currently 81.32%.

HCP Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Read More: Intrinsic Value and Stock Selection

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

BonusCloud Market Capitalization Achieves $1.15 Million
BonusCloud Market Capitalization Achieves $1.15 Million
IONChain Market Capitalization Achieves $694,054.00
IONChain Market Capitalization Achieves $694,054.00
Anoncoin  Trading 43% Lower  This Week
Anoncoin Trading 43% Lower This Week
Rocky Brands Inc  Given $31.00 Average Target Price by Analysts
Rocky Brands Inc Given $31.00 Average Target Price by Analysts
AC Immune  Trading Up 5.8%
AC Immune Trading Up 5.8%
VirnetX  Stock Price Up 9.4%
VirnetX Stock Price Up 9.4%


 
© 2006-2019 Zolmax.